Home > Financial Ratios > GLAND PHARMA

GLAND PHARMA
Working Capital/Sales

    Back to All Ratios
GLAND PHARMA is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for GLAND PHARMA
Please provide your vote to see the results

GLAND PHARMA Last 5 Year Working Capital/Sales History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Working Capital/Sales(x) 1.081.330.590.840.75

What is the latest Working Capital/Sales ratio of GLAND PHARMA ?

The latest Working Capital/Sales ratio of GLAND PHARMA is 1.08 based on Mar2025 Consolidated results.
Year Working Capital/Sales
Mar20251.08
Mar20241.33
Mar20230.59
Mar20220.84
Mar20210.75

How is Working Capital/Sales of GLAND PHARMA Trending?

Years Working Capital/Sales % Change
Mar2025 1.08
-18.80
Mar2024 1.33
125.42
Mar2023 0.59
-29.76
Mar2022 0.84
12.00
Mar2021 0.75 -

Other Financial Ratios of GLAND PHARMA


Compare Working Capital/Sales ratio of peers of GLAND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLAND PHARMA ₹30,109.0 Cr -1.8% -5.3% 1.5% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹416,477.0 Cr 2.5% 4% -3.3% Stock Analytics
DIVIS LABORATORIES ₹174,934.0 Cr -1% 0.5% 9.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹129,469.0 Cr 6.9% 8.7% 21% Stock Analytics
CIPLA ₹123,250.0 Cr 1.4% -2.4% -3.4% Stock Analytics
DR REDDYS LABORATORIES ₹103,038.0 Cr 2.4% -2.2% -4.5% Stock Analytics


GLAND PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
GLAND PHARMA

-1.8%

-5.3%

1.5%

SENSEX

1.4%

2.4%

5.1%


You may also like the below Video Courses